AIM ImmunoTech Inc.
corporate_fare Company Profile
AIM ImmunoTech Inc. (NYSE:AIM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for AIM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Recent SEC coverage for AIM spans 10-Q.
Recent high-impact activity:
- AIM ImmunoTech 10-Q: Going Concern Warning, $10.0M Nine-Month Loss, 47.4M Warrants Outstanding
Financial Snapshot
Short Interest & Short Volume
2.46 days to coverFINRA reported short interest of 1,002,082 shares in AIM as of the October 30, 2026 settlement, a 7.2% decrease from the prior period — about 2.5 days to cover at its recent average daily volume. On November 20, 2026, 26.4% of AIM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.